TYRA Tyra Biosciences falls 335 after widerthanexpected Q4 2025 earnings loss dents investor confidence Why Nuveen JMM ability to execute stands out Slow Grind 20260511 Gilead Sciences GILD Partner Tempus AI TEM Secures TD Cowen Buy Upgrade Amid AI Drug Development Traction Centene Corporation CNC David Einhorns Greenlight Capital Ramps Up Stake Amid Bullish Fundamental Catalysts Zentalis Pharmaceuticals Strengthens Leadership with New Board Member and Commercial Executive Ahead of Key Trial Results Alphabet Hosts Q1 2026 Earnings Call Investors Eye Cloud and AI Growth Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Evolving Cybersecurity Demand Trends STERIS Stock Outlook Wall Street Analysts Assess Potential Upside and Risks AI Industry Emerges as Key Beneficiary in MuskAltman Trial Suggesting Increased Sector Transparency Agnico Eagle Mines Announces 24 Billion Hope Bay Mine Redevelopment Amid Strong Earnings Momentum MTA Q1 2026 Earnings Narrowly Positive EPS Despite Significant Miss NVNI Q4 2025 Earnings Massive EPS Miss Sends Shockwaves as Revenue Figures Remain Undisclosed Genie Energy Ltd GNE Q1 2026 Earnings EPS Misses Estimates as Revenue Data Remain Unavailable OS Therapies OSTX Q4 2025 Earnings WiderThanExpected Loss Weighs on Shares SWX Q1 2026 Earnings EPS Falls Short of Estimates Amid Operational Pressures KE Q1 2026 Earnings EPS Slightly Misses Estimates Amidst Operational Challenges Rithm Capital RITM Holds Steady at 926 as Markets Eye Key Support and Resistance Levels BILL Holdings Shows Signs of Stabilization as Price Tests Key Resistance CIMP Holds Near Par as Chimera Investment Corporation Notes Show Modest Gains Amid Rate Uncertainty Larimar Therapeutics LRMR Holds Steady Near Support After Modest Gain TDS Shares Decline Sharply as Selling Pressure Intensifies Morgan Stanley Maintains Bullish Stance on NextEra Energy Despite Price Target Reduction Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones EXG Inches Higher as Global Diversified Income Fund Trades Near Midpoint of Range